OTC Pharmaceuticals - Togo

  • Togo
  • Revenue in the OTC Pharmaceuticals market amounts to US$33.93m in 2024. The market is expected to grow annually by 9.17% (CAGR 2024-2029).
  • The market's largest segment is the segment Skin Treatment with a market volume of US$9.53m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$3.66 are generated in 2024.
  • In the OTC Pharmaceuticals market, 6.8% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Togo has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences in Togo have shifted towards self-medication and a preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to a growing awareness of health and wellness, as well as an increasing desire for convenience and accessibility. Customers are now seeking quick and effective remedies for common ailments, such as headaches, colds, and allergies, which can be easily obtained without a prescription.

Trends in the market reflect the changing customer preferences. The availability of a wide range of OTC pharmaceutical products in pharmacies and drugstores has increased, providing customers with a greater variety of options. Additionally, there has been an increase in the number of pharmacies and drugstores in Togo, further improving accessibility to OTC products.

This expansion of distribution channels has been driven by both local and international pharmaceutical companies, recognizing the potential for growth in the market. Local special circumstances in Togo have also played a role in the development of the OTC Pharmaceuticals market. The country has a relatively underdeveloped healthcare infrastructure, with limited access to healthcare facilities and medical professionals, particularly in rural areas.

This has led to an increased reliance on self-medication and OTC pharmaceutical products as a primary form of healthcare. Furthermore, the affordability of OTC products compared to prescription medications has made them a more attractive option for many Togolese consumers. Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Togo.

The country has experienced steady economic growth in recent years, resulting in an increase in disposable income and consumer spending. This has allowed more individuals to afford OTC pharmaceutical products and has contributed to the overall growth of the market. Additionally, the government of Togo has implemented policies to promote the development of the healthcare sector, including the improvement of healthcare infrastructure and the regulation of pharmaceutical products.

These initiatives have created a favorable environment for the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Togo is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the availability of a wide range of OTC products, limited access to healthcare facilities, and steady economic growth have all contributed to the growth of the market.

As these factors continue to evolve, the OTC Pharmaceuticals market in Togo is expected to further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)